Inactive Instrument

Other languages Can B Corp. Other OTC

Equities

CANBD

US13470W1036

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Can B Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 20
Can B Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 15
Can B : New Financial Obligation - Form 8-K	Mar. 21
Can B Corp. Secures Ownership and Control of Two Cannabis Patents Valued at $122 Million and Potentially in Excess of $750 Million	Mar. 11
Can B Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 20
Can B Corp. Expects Nearly $500,000 Annual Savings With Successful Completion of Move of Pure Health Products From Lacey, WA to Colorado	23-10-10
Can B Corp. Announces its Move and Consolidation of its Pure Health Product Operations from Lacey, WA to Colorado	23-10-10
Can B Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-21
Can B Corp. Secures 1.8 Million Pounds of Biomass for Awarded Contract With One Bad Moon Rising	23-07-20
Can B Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-22
Can B Corp. Reports Growth of 45% to Company All-Time High $6.7 Million Annual Revenue	23-04-19
CAN B CORP Management's Discussion and Analysis of Financial Condition and Results of Operation (form 10-K)	23-04-17
Can B Corp. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17
Can B Corp. Auditor Raises 'Going Concern' Doubt	23-04-16
Can B Corp. Completes Corporate Debt Restructuring to Position for Uplisting to National Securities Exchange	23-03-15
CAN B CORP : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities (form 8-K)	23-03-09
Can B Corp. announced that it has received $1.55 million in funding	23-03-01
Can B Corp. announced that it expects to receive $1.55 million in funding	23-02-26
Can B Corp. Reports Growth of 51% to $2.9 Million Revenue for Third Quarter 2022, the Highest Quarterly Revenue in Company History	22-11-22
CAN B CORP MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-21

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Can B Corp. Other OTC

Equities

CANBD

US13470W1036

Other languages

Filters